Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Biocept Inc (NASDAQ: BIOC)

$1.51 USD $0.06 (4.14%)
Last Price $1.51
Net Change $0.06 (4.14%)
Bid $0
Ask Price $0
Open Price $1.43
Previous Close Price $1.45
High Price $1.52
Low Price $1.43
Number of Trades 1,649
Volume 667,600
Fifty Two Week High $3.39 (2017-01-11)
Fifty Two Week Low $0.74 (2016-11-04)
Average Daily Volume 2,503,509
Share Outstanding 26,600 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $57.81
Recent Earnings $
Annual EPS $-1.65
Last Quarter EPS $
Market Capitalization $0.04B
Insider Shareholders % 0.077%
Annual Revenue $0B
No. Shares Outstanding 26,600
Inst. Shareholder % 14.57%
Annual Net Income $-0.02B
TTM Net Profit Margin $-383.55
1-Year Return -20.11%
3-Year Return -88.64%
5-Year Return -94.65%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 57.810001%
Dividends per Share $
Stock Split Ratio 1-3
Beta 3
Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.